Recognizing the massive room for sampling bias when characterizing metastatic disease with a single tissue biopsy approach, this intriguing meta-analysis demonstrates specific genetic alterations detected via circulating tumor DNA evaluation at diagnosis of stage IV breast cancer are significantly associated with survival outcomes, paving the way for future therapeutic implications. | Dickinson, JAMA Netw Open 2024
